Clinical study of Docetaxel and Xeloda combination in the treatment of patients with metastatic breast cancer

@inproceedings{Qiuyang2011ClinicalSO,
  title={Clinical study of Docetaxel and Xeloda combination in the treatment of patients with metastatic breast cancer},
  author={He Qiuyang},
  year={2011}
}
Objective:To study the efficacy and toxicity of Docetaxel and Xeloda combination regimen in treatment of patients with metastatic breast cancer.Methods:Fifty-six patients received Docetaxel and Xeloda combination regimen,namely,Docetaxel 75 mg/m2 ivgtt,day1;Xeloda 900 mg/m2,twice daily.The regimen was repeated every 21 days and the clinical response was recorded after four cycles.Results:Fifty-six patients were evaluated that who obtain better curative effect.The main toxicities were… CONTINUE READING

Topics from this paper.